Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations (Unaudited)

v3.25.4
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]        
Revenues $ 14,121,000 $ 16,830,000 $ 27,296,000 $ 32,955,000
Cost of sales 9,226,000 11,367,000 18,636,000 22,274,000
Gross profit 4,895,000 5,463,000 8,660,000 10,681,000
Operating expenses:        
Selling and administrative 3,564,000 5,985,000 8,470,000 11,100,000
Research and development 536,000 957,000 1,573,000 2,272,000
Total operating expenses 4,100,000 6,942,000 10,043,000 13,372,000
Operating income (loss) 795,000 (1,479,000) (1,383,000) (2,691,000)
Interest income (expense), net (194,000) (408,000) (578,000) (865,000)
Net income (loss) $ 601,000 $ (1,887,000) $ (1,961,000) $ (3,556,000)
Net income (loss) per share - basic $ 0.03 $ (0.11) $ (0.11) $ (0.21)
Net income (loss) per share - diluted $ 0.03 $ (0.11) $ (0.11) $ (0.21)
Weighted average number of common shares outstanding - basic 19,686,961 16,682,465 18,261,330 16,682,465
Weighted average number of common shares outstanding - diluted 22,858,593 16,682,465 18,261,330 16,682,465